120 related articles for article (PubMed ID: 35717784)
1. Effect of sarpogrelate treatment on 5-HT modulation of vascular sympathetic innervation and platelet activity in diabetic rats.
Fernández-González JF; García-Pedraza JÁ; Marín-Quílez A; Bastida JM; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2022 Sep; 153():113276. PubMed ID: 35717784
[TBL] [Abstract][Full Text] [Related]
2. Chronic sarpogrelate treatment improves renal sympathetic hyperactivity in experimental diabetes.
Fernández-González JF; García-Pedraza JÁ; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Biomed Pharmacother; 2024 Jul; 176():116814. PubMed ID: 38820974
[TBL] [Abstract][Full Text] [Related]
3. Oral fluoxetine treatment changes serotonergic sympatho-regulation in experimental type 1 diabetes.
García-Pedraza JÁ; Fernández-González JF; López C; Martín ML; Alarcón-Torrecillas C; Rodríguez-Barbero A; Morán A; García-Domingo M
Life Sci; 2022 Mar; 293():120335. PubMed ID: 35051421
[TBL] [Abstract][Full Text] [Related]
4. Peripheral 5-HT₁D and 5-HT₇ serotonergic receptors modulate sympathetic neurotransmission in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; Gómez-Escudero J; Rodríguez-Barbero A; Román LS; Morán A
Eur J Pharmacol; 2013 Aug; 714(1-3):65-73. PubMed ID: 23769743
[TBL] [Abstract][Full Text] [Related]
5. Blockade of 5-HT
Hernández-Abreu OI; García-Pedraza JÁ; Rivera-Mancilla E; Villanueva-Castillo B; Morán A; García-Domingo M; Manrique-Maldonado G; Altamirano-Espinoza AH; Villalón CM
Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):403-411. PubMed ID: 31846086
[TBL] [Abstract][Full Text] [Related]
6. Chronic 5-HT
García-Pedraza JÁ; Hernández-Abreu O; García M; Morán A; Villalón CM
Can J Physiol Pharmacol; 2018 Apr; 96(4):328-336. PubMed ID: 28886249
[TBL] [Abstract][Full Text] [Related]
7. Vascular sympathetic neurotransmission and its serotonergic regulation are modified by chronic fluoxetine treatment.
García-Pedraza JÁ; López C; Fernández-González JF; Martín ML; Morán A; García-Domingo M
J Pharmacol Sci; 2021 Sep; 147(1):48-57. PubMed ID: 34294372
[TBL] [Abstract][Full Text] [Related]
8. Renal Sympathetic Hyperactivity in Diabetes Is Modulated by 5-HT
Fernández-González JF; García-Pedraza JÁ; Ordóñez JL; Terol-Úbeda AC; Martín ML; Morán A; García-Domingo M
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674892
[TBL] [Abstract][Full Text] [Related]
9. Role of peripheral 5-HT
García-Pedraza JÁ; Hernández-Abreu O; Morán A; Carretero J; García-Domingo M; Villalón CM
Sci Rep; 2020 Nov; 10(1):19358. PubMed ID: 33168874
[TBL] [Abstract][Full Text] [Related]
10. The role of endothelium-derived hyperpolarizing factor and cyclooxygenase pathways in the inhibitory serotonergic response to the pressor effect elicited by sympathetic stimulation in chronic sarpogrelate treated rats.
García-Pedraza JÁ; García M; Martín ML; San Román L; Morán A
Eur J Pharmacol; 2014 May; 731():80-7. PubMed ID: 24675150
[TBL] [Abstract][Full Text] [Related]
11. 5-HT modulates the rat mesenteric vasopressor outflow by 5-HT
García-Pedraza JÁ; García-Domingo M; Gómez-Roso M; Rodríguez-Barbero A; Martín ML; Morán A
Clin Exp Pharmacol Physiol; 2017 Dec; 44(12):1224-1231. PubMed ID: 28771848
[TBL] [Abstract][Full Text] [Related]
12. 5-HT2 receptor blockade exhibits 5-HT vasodilator effects via nitric oxide, prostacyclin and ATP-sensitive potassium channels in rat renal vasculature.
García-Pedraza JA; García M; Martín ML; Rodríguez-Barbero A; Morán A
Vascul Pharmacol; 2016 Apr; 79():51-59. PubMed ID: 26586311
[TBL] [Abstract][Full Text] [Related]
13. 5-HT1D receptor inhibits renal sympathetic neurotransmission by nitric oxide pathway in anesthetized rats.
García-Pedraza JÁ; García M; Martín ML; Morán A
Vascul Pharmacol; 2015 Sep; 72():172-80. PubMed ID: 26003124
[TBL] [Abstract][Full Text] [Related]
14. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats.
Morán A; Restrepo B; de Urbina AV; García M; Martín ML; Román LS
Eur J Pharmacol; 2010 Sep; 643(1):70-7. PubMed ID: 20547148
[TBL] [Abstract][Full Text] [Related]
15. Blockade of serotonin 2A receptor improves glomerular endothelial function in rats with streptozotocin-induced diabetic nephropathy.
Kobayashi S; Satoh M; Namikoshi T; Haruna Y; Fujimoto S; Arakawa S; Komai N; Tomita N; Sasaki T; Kashihara N
Clin Exp Nephrol; 2008 Apr; 12(2):119-125. PubMed ID: 18175064
[TBL] [Abstract][Full Text] [Related]
16. Effect of sarpogrelate on altered STZ-diabetes induced cardiovascular responses to 5-hydroxytryptamine in rats.
Umrani DN; Bodiwala DN; Goyal RK
Mol Cell Biochem; 2003 Jul; 249(1-2):53-7. PubMed ID: 12956398
[TBL] [Abstract][Full Text] [Related]
17. Chronic Sarpogrelate Treatment Reveals 5-HT7 Receptor in the Serotonergic Inhibition of the Rat Vagal Bradycardia.
García-Pedraza JÁ; García M; Martín ML; Eleno N; Morán A
J Cardiovasc Pharmacol; 2017 Jan; 69(1):13-22. PubMed ID: 27676327
[TBL] [Abstract][Full Text] [Related]
18. Evidence that chronic administration of 17β-oestradiol decreases the vasopressor responses to adrenergic system stimulation in streptozotocin-diabetic female rats.
Acosta-Cota SJ; Sánchez-López A; Molina-Muñoz T; Gómez-Viquez NL; Centurión D
Steroids; 2014 May; 83():1-9. PubMed ID: 24513052
[TBL] [Abstract][Full Text] [Related]
19. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes.
Villamil-Hernández MT; Alcántara-Vázquez O; Sánchez-López A; Centurión D
Eur J Pharmacol; 2013 Oct; 718(1-3):245-52. PubMed ID: 24028939
[TBL] [Abstract][Full Text] [Related]
20. Diabetes-induced changes in 5-hydroxytryptamine modulation of vagally-induced bradycardia in rat heart.
García M; Morán A; Martín ML; Ortizde Urbina AV; San Román L
Clin Exp Pharmacol Physiol; 2007 Nov; 34(11):1199-206. PubMed ID: 17880377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]